Tetra Tech: Q4 Earnings Insights

Tetra Tech (NASDAQ:TTEK) reported its Q4 earnings results on Wednesday, November 15, 2023 at 04:04 PM. Here’s what…

Tetra Tech (NASDAQ:TTEK) reported its Q4 earnings results on Wednesday, November 15, 2023 at 04:04 PM.

Here’s what investors need to know about the announcement.

Earnings

Tetra Tech beat estimated earnings by 24.48%, reporting an EPS of $1.78 versus an estimate of $1.43.

Revenue was up $320.88 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.11 which was followed by a 0.91% drop in the share price the next day.

Here’s a look at Tetra Tech’s past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate 1.18 1.03 1.21 1.15
EPS Actual 1.29 1.17 1.34 1.26
Revenue Estimate 959.32M 826.37M 717.73M 712.88M
Revenue Actual 987.56M 969.57M 736.56M 736.12M

To track all earnings releases for Tetra Tech visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Prelude Therapeutics Reports FY23 Financial Results And Outlines Key Objectives For 2024; FY23 EPS $(2.02) Vs $(2.44) YoY; Current Cash Runway Into 2026 With $232.9M In Cash, Cash Equivalents And Marketable Securities As Of December 31, 2023

First-in-class IV SMARCA2 degrader and potentially best-in-class CDK9 inhibitor on track to generate potential proof-of-concept data in 2024 Highly selective oral SMARCA2 degrader PRT7732 IND expected to be filed in

PRLD